ea0026p289 | Pituitary | ECE2011
Rossi V
, Bellastella G
, Staibano S
, Ilardi G
, Del Basso De Caro M L
, Cavallo L
, Cappabianca P
, Abbondanza C
, Colao A
, Bellastella A
, Sinisi A A
Pasireotide (SOM230), a somatostatin (SST) analogue targeting multiple SST receptors, is effective in reducing urinary free cortisol in patients with Cushing disease (CD), due to inoperable or recurrent ACTH secreting pituitary adenomas. The efficacy of SOM230 seems to be dependent on the presence of appropriate SSTRs, mainly SSTR2 and 5, on the membrane of tumor cells. Polyclonal antibodies available up to now recognizing cellular intracellular sites of receptors and their re...